NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma

IntroductionImproving treatments for Diffuse Large B-Cell Lymphoma (DLBCL) is challenged by the vast heterogeneity of the disease. Nuclear factor-κB (NF-κB) is frequently aberrantly activated in DLBCL. Transcriptionally active NF-κB is a dimer containing either RelA, RelB or cRel, but the variabilit...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Eleanor Jayawant, Arran Pack, Heather Clark, Emma Kennedy, Ankur Ghodke, John Jones, Chris Pepper, Andrea Pepper, Simon Mitchell
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Frontiers Media S.A. 2023-06-01
Sarja:Frontiers in Oncology
Aiheet:
Linkit:https://www.frontiersin.org/articles/10.3389/fonc.2023.1181660/full